Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Clinical-trials-phase-ii crawled date : 2021 - 09 - 13 save search
Additional Data from Hepion Pharmaceuticals’ Phase 2a ‘AMBITION’ Trial Further Strengthens CRV431 Clinical Profile and Paves Way for Initiation of Phase 2b ‘ASCEND-NASH’ Clinical Program
Published: 2021-09-13 (Crawled : 19:00) - biospace.com/
HEPA | $2.11 -0.09% -0.09% 73K
|
Health Technology
|
| O: 4.82%
H: 0.57%
C: -3.45%
phase 2 phase 2b nash trial crv431
MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan
Published: 2021-09-13 (Crawled : 18:00) - biospace.com/
MYMD | $2.54 0.8% 0.79% 18K
|
Manufacturing
|
| O: 1.55%
H: 0.0%
C: -10.69%
phase 2 trial
Leap Therapeutics to Present New Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ESMO 2021 Congress
Published: 2021-09-13 (Crawled : 14:00) - biospace.com/
LPTX | $2.81 -5.07% -5.34% 200K
|
Health Technology
|
| O: 28.08%
H: 2.67%
C: -5.35%
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: 0.0%
H: 4.26%
C: 3.47%
Instil Bio Receives IND Clearance to Initiate a Phase 2 Clinical Trial for Patients with Advanced Melanoma
Published: 2021-09-13 (Crawled : 13:00) - biospace.com/
TIL | $10.53 1.15% 1.14% 9.9K
|
Professional, Scientific, and T...
|
| O: -0.32%
H: 5.27%
C: -3.01%
phase 2 trial clearance
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.